Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-03-08
2011-03-08
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07902171
ABSTRACT:
The present invention relates to the use of hyaluronic acid for treating inflammatory diseases, in particular skin or mucous membrane diseases.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs et al.
patent: 4713448 (1987-12-01), Balazs et al.
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 5679655 (1997-10-01), Gallina
patent: 5728391 (1998-03-01), Ikeya et al.
patent: 5830882 (1998-11-01), Falk et al.
patent: 5910489 (1999-06-01), Falk et al.
patent: 5914322 (1999-06-01), Falk et al.
patent: 6455066 (2002-09-01), Fischer et al.
patent: 2004/0136925 (2004-07-01), Petrigni et al.
patent: 2005/0043271 (2005-02-01), Gross et al.
patent: 2005/0137164 (2005-06-01), Arkin et al.
patent: 2005/0164979 (2005-07-01), Gross et al.
patent: 2005/0187185 (2005-08-01), Reinmuller
patent: 102 09 966 (2003-05-01), None
patent: 10209966 (2003-05-01), None
patent: 0161887 (1991-09-01), None
patent: 0 715 852 (1996-06-01), None
patent: WO 00/44367 (2000-08-01), None
patent: WO-03 049747 (2003-06-01), None
patent: WO-03 053452 (2003-07-01), None
Definition of prevention, Merriam-Webster Online Dictionary [retrieved: Aug. 15, 2008].
Definition of “inflammation” from Stedman's Medical Dictionary. [online, retrieved on Oct. 7, 2008].
Leshchinskii, a.f., Zuza, Z.I., Barkagan, T.S. (1972) Pathogenesis of inflammation and mechanism of the anti-inflammatory action of experimental pelotherapy. Bulletin of Experimental Biology and Medicine, vol. 73, No. 4, p. 384-387.
Wilkinson, G.R. (2001) “Pharmacokinetics, The Dynamics of Drug Absorption, Distribution, and Elimination” in Goodman and Gilman's The Pharmacological Basis of Therapeutics. editors Joel G. Hardman and lee E. Limbird, published by The McGraw-Hill Companies, Inc., p. 24-26.
Sterling, J.C., Handfield-Jones, S., Hudson, P.M. (2001) Guidelines for the management of cutaneous warts. British Journal of Dermatology, vol. 144, p. 4-11.
Stanberry, L.R. (1991) Evaluation of Herpes Simplex Virus Vaccines in Animals: The Guniea Pig Vaginal Model. Reviews of Infectious Diseases, vol. 13, No. 11, p. S920-S923.
“Artificial Skin Powder Composition Containing Sodium Hyaluronate and Its Preparation”; Derwent, Jul. 25, 2000, XP002232150.
Volpi, Nicola et al., “Role, Metabolism, Chemical Modifications and Applications of Hyaluronan,” Current Medicinal Chemistry, 2009, vol. 16, pp. 1718-1745.
Dirting Kay
Reinmüller Johannes
Goon Scarlett
Jiang Shaojia Anna
Millen White Zelano & Branigan P.C.
LandOfFree
Composition for treating inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating inflammatory diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2682857